WP1066

WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3. WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms.

Price Not Available 5 mg WP1066 Supplier Page

Catalog Number	T2156
Research Area	Chromatin/Epigenetic\|\|\|Stem Cells\|\|\|JAK/STAT signaling\|\|\|Angiogenesis\|\|\|Apoptosis
Molecular Formula	C17H14BrN3O
CAS#	857064-38-1
Purity	99.07%
SMILES	C[C@@H](c1ccccc1)NC(=O)/C(=C/c1nc(ccc1)Br)/C#N
Size	5 mg
Supplier Page	https://www.targetmol.com/compound/WP1066
Additional Information	https://www.targetmol.com/datasheet/T2156